Editas Medicine(CH:8EM)
CHF 1.77-0.08 (-4.07%)
CH:8EM
Editas Medicine earnings date
CHF 1.77
At close:-0.08 (-4.07%)
Editas Medicine (8EM) Q4 2023 Earnings Report
1 Followers
CH:8EM Q4 2023 EPS Results
- Actual EPS
- -CHF 0.19
- Consensus EPS
- -CHF 0.50
- Beat/Miss
- Beat by +CHF 0.31
- One Year Ago EPS
- -CHF 0.74
CH:8EM Q4 2023 Revenue Results
- Actual Revenue
- CHF 50.36M
- Expected Revenue
- CHF 3.10M
- Beat/Miss
- Beat by +CHF 47.26M
- YoY Revenue Growth
- +818.74%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/28/2024
- Time
- Before Open
- Conference Call
- Wednesday, February 28, 2024
CH:8EM Upcoming Earnings
Editas Medicine's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
CH:8EM Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:8EM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.15- | -0.05 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.16-0.13 | -0.23 | 46.43% (+0.11) | |
| Aug 05, 2026 | 2026 (Q2) | -0.23-0.13 | -0.53 | 76.19% (+0.40) | |
| May 05, 2026 | 2026 (Q1) | -0.22-0.22 | -0.77 | 71.74% (+0.55) | |
| Mar 09, 2026 | 2025 (Q4) | -0.20-0.05 | -0.46 | 89.09% (+0.41) | |
| Nov 10, 2025 | 2025 (Q3) | -0.25-0.23 | -0.63 | 62.67% (+0.39) | |
| Aug 12, 2025 | 2025 (Q2) | -0.33-0.53 | -0.69 | 23.17% (+0.16) | |
| May 12, 2025 | 2025 (Q1) | -0.47-0.77 | -0.64 | -21.05% (-0.13) | |
| Mar 05, 2025 | 2024 (Q4) | -0.32-0.46 | -0.19 | -139.13% (-0.27) | |
| Nov 04, 2024 | 2024 (Q3) | -0.63-0.63 | -0.46 | -36.36% (-0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
